Picture of Cabaletta Bio logo

CABA Cabaletta Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Cabaletta Bio Reports Q3 2022 Financial Results

Nov 10 (Reuters) - Cabaletta Bio Inc  CABA.O :
    * CABALETTA BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
    * CABALETTA BIO - AS OF SEPTEMBER 30, 2022, CO HAD CASH,
CASH
EQUIVALENTS AND INVESTMENTS OF $85.9 MILLION, COMPARED TO $122.2
MILLION AS OF DECEMBER 31, 2021
    * CABALETTA BIO - EXPECTS THAT CASH, CASH
EQUIVALENTS,INVESTMENTS
AS OF SEPTEMBER 30, 2022, WILL ENABLE IT TO FUND ITS OPERATING
PLAN THROUGH Q2 OF 2024
    * QTRLY LOSS PER SHARE $0.39
    * Q3 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3ch3SK 
Further company coverage:  CABA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cabaletta Bio

See all news